GeneID: 343



Names

Common Name: TR2 Type: Gene
Chromosome: 12 (NC_000012.12) Locus: NM_003297.4 (NR2C1)
HUGO Symbol: NR2C1 Full Name: nuclear receptor subfamily 2 group C member 1
Exons: 14 Introns: 13

Description:
This gene encodes a protein that belongs to the nuclear hormone receptor family, the testicular receptor 2 (NR2C1, TR2). Members of this family function in many biological processes such as development, cellular differentiation and homeostasis. It is characterized by a highly conserved DNA binding domain (DBD), a variable hinge region, and a carboxy-terminal ligand binding domain (LBD) that is typical for all members of the nuclear receptor superfamily. This protein also belongs to a large family of ligand-inducible transcription factors that regulate gene expression by binding to specific DNA sequences within promoters of target genes. Together with NR2C2 (TR4), forms the core of the DRED (direct repeat erythroid-definitive) complex that binds to direct repeat (DR) elements (AGGTCA repeats) localised in the promoters of the ε- and γ-globin genes, repressing their expression in definitive erythroid cells. In addition to the orphan nuclear receptors TR2 (NR2C1) and TR4 (NR2C2), the DRED complex also includes two co-repressor enzymes, namely DNA methyltransferase 1 (DMNT1) and lysine-specific demethylase 1 (LSD1). Experimental evidence suggests that the TR2/TR4 complex is a stage-selective repressor of embryonic and fetal globin genes. However, forced expression of this complex in β-YAC transgenic mice and a humanized sickle cell disease (SCD) mouse model led to induction of the fetal γ-globin gene in adult erythroid cells and, in turn, to effective reversal of the disease phenotype. Modulating the activity of the TR2 and TR4 nuclear receptors could thus offer a promising therapeutic strategy for the treatment of SCD and β-thalassaemia.

Synonyms: N/A

Comments:
N/A

Number of entries/variants: 0

IthaScore

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage.

Publications / Origin

  1. Tanabe O, McPhee D, Kobayashi S, Shen Y, Brandt W, Jiang X, Campbell AD, Chen YT, Chang Cs, Yamamoto M, Tanimoto K, Engel JD, Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4., EMBO J., 26(9), 2295-306, 2007 PubMed
  2. Campbell AD, Cui S, Shi L, Urbonya R, Mathias A, Bradley K, Bonsu KO, Douglas RR, Halford B, Schmidt L, Harro D, Giacherio D, Tanimoto K, Tanabe O, Engel JD, Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes., Proc. Natl. Acad. Sci. U.S.A., 108(46), 18808-13, 2011 PubMed
Created on 2020-01-08 09:04:13, Last reviewed on 2022-11-30 16:24:05 (Show full history)


Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.